These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 21694443

  • 21. Intrarenal expression of microRNAs in patients with IgA nephropathy.
    Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, Szeto CC.
    Lab Invest; 2010 Jan; 90(1):98-103. PubMed ID: 19901913
    [Abstract] [Full Text] [Related]

  • 22. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.
    Cao Y, Wang Y, Liu Y, Zhu X, Zhang G, Wang S, Chen X, Liu D, Fu C.
    Dis Markers; 2019 Jan; 2019():2424751. PubMed ID: 31485275
    [Abstract] [Full Text] [Related]

  • 23. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
    Ranieri E, Gesualdo L, Petrarulo F, Schena FP.
    Kidney Int; 1996 Dec; 50(6):1990-2001. PubMed ID: 8943482
    [Abstract] [Full Text] [Related]

  • 24. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease.
    Szeto CC, Ng JK, Fung WW, Chan GC, Luk CC, Lai KB, Wang G, Chow KM, Mac-Moune Lai F.
    Clin Chim Acta; 2022 May 01; 530():81-86. PubMed ID: 35278407
    [Abstract] [Full Text] [Related]

  • 25. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar 01; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 26. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
    Zhang M, Duan ZY, Zhang QY, Xu XG, Zhang Y, Wang P, Duan SW, Wu J, Chen XM, Cai GY.
    Sci Rep; 2023 Apr 13; 13(1):6048. PubMed ID: 37055445
    [Abstract] [Full Text] [Related]

  • 27. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
    Fan Q, Lu R, Zhu M, Yan Y, Guo X, Qian Y, Zhang L, Dai H, Ni Z, Gu L.
    Nephron; 2019 Apr 13; 142(3):195-207. PubMed ID: 30808829
    [Abstract] [Full Text] [Related]

  • 28. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
    Feng Y, Lv LL, Wu WJ, Li ZL, Chen J, Ni HF, Zhou LT, Tang TT, Wang FM, Wang B, Chen PS, Crowley SD, Liu BC.
    Am J Pathol; 2018 Nov 13; 188(11):2542-2552. PubMed ID: 30142333
    [Abstract] [Full Text] [Related]

  • 29. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
    Sasaki Y, Shimizu Y, Suzuki Y, Horikoshi S, Tomino Y.
    BMC Nephrol; 2015 Mar 14; 16():27. PubMed ID: 25885587
    [Abstract] [Full Text] [Related]

  • 30. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May 14; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, Zhu XJ, Liu FY.
    Ren Fail; 2012 May 14; 34(7):821-6. PubMed ID: 22679920
    [Abstract] [Full Text] [Related]

  • 32. Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy.
    Cox SN, Chiurlia S, Divella C, Rossini M, Serino G, Bonomini M, Sirolli V, Aiello FB, Zaza G, Squarzoni I, Gangemi C, Stangou M, Papagianni A, Haas M, Schena FP.
    Sci Rep; 2020 Sep 16; 10(1):15164. PubMed ID: 32938960
    [Abstract] [Full Text] [Related]

  • 33. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
    Liu LL, Jiang Y, Wang LN, Liu N.
    Clin Exp Immunol; 2012 Aug 16; 169(2):148-55. PubMed ID: 22774989
    [Abstract] [Full Text] [Related]

  • 34. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
    Zhao S, Sun Y, Mao Q, Zhou C, Chen Y, Xue D.
    Nephron; 2022 Aug 16; 146(6):539-552. PubMed ID: 35381590
    [Abstract] [Full Text] [Related]

  • 35. Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy.
    Waga I, Yamamoto J, Sasai H, Munger WE, Hogan SL, Preston GA, Sun HW, Jennette JC, Falk RJ, Alcorta DA.
    Kidney Int; 2003 Oct 16; 64(4):1253-64. PubMed ID: 12969143
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
    Ciferska H, Honsova E, Lodererova A, Hruskova Z, Neprasova M, Vachek J, Suchanek M, Zima T, Coppo R, Tesar V, Novak J, Maixnerova D.
    J Nephrol; 2020 Apr 16; 33(2):307-316. PubMed ID: 31489594
    [Abstract] [Full Text] [Related]

  • 38. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K.
    Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628
    [Abstract] [Full Text] [Related]

  • 39. Lower urinary-interleukin-1 receptor-antagonist excretion in IgA nephropathy than in Henoch-Schönlein nephritis.
    Rauta V, Teppo AM, Törnroth T, Honkanen E, Grönhagen-Riska C.
    Nephrol Dial Transplant; 2003 Sep 11; 18(9):1785-91. PubMed ID: 12937225
    [Abstract] [Full Text] [Related]

  • 40. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
    Hu H, Wan Q, Li T, Qi D, Dong X, Xu Y, Chen H, Liu H, Huang H, Wei C, Zhou W, Jiang S, Mo Z, Liao F, Xu Q, He Y.
    Iran J Kidney Dis; 2020 Mar 11; 14(2):107-118. PubMed ID: 32165595
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.